As many of you are aware, MPOG was selected by the Patient Centered Outcomes Research Institute (PCORI) to conduct a study to assess the Trajectories of Recovery after the use of IntraVenous propofol versus inhaled VolatilE anesthesia (THRIVE). We are seeking at least 12 MPOG enrollment sites to conduct this 12,500-patient randomized controlled trial. More information about the trial and anticipated timelines can be found at https://mpog.org/thrive-info/. 

We recently distributed a Site Feasibility Questionnaire (SFQ) to all participating MPOG sites via email – also available at https://mpog.org/thrive-information-for-interested-sites/. Please send any questions related to the trial and completed SFQs by May 2, 2022 to anest-THRIVEStudy@email.wustl.edu. 

We are hopeful you will be interested in participating and look forward to working with you.